CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

April 16th, 2010

FDA Permits Boston Scientific to Resume Sales of Most ICDs

FDA Permits Boston Scientific to Resume Sales of Most ICDs: Following a 30-day suspension of sales of Boston Scientific ICDs and CRT-Ds, the FDA has given the company a green light to resume sales of most, but not all, of these devices. The suspension occurred after the company made significant manufacturing changes without following FDA approval procedures. Boston Scientific said sales of its current generation of devices, Cognis CRT-Ds and Teligen ICDs, would resume immediately. (Boston Scientific press release; New York Times story.)

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.